USANA HEALTH SCIENCES INC(USNA)— Stock Profile, AI Score & Financials

Healthcare · NYSE · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-07-04.

USANA HEALTH SCIENCES INC (USNA) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores USNA at 38.4/100 on a 32-signal composite quality model, placing it at rank #2,195 of 2,962 stocks — the bottom half of the AI-ranked universe. USNA scores in the top quartile across institutional flow (77.6). Areas of concern include profitability (24.1) and balance sheet strength (26.2), which score below median versus the broader universe. Shareholder dilution risk is elevated at 46.4/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), USANA HEALTH SCIENCES INC reports quarterly revenue of $223.3M, net income of $-21.4M, free cash flow of $20.2M. USNA trades on the NYSE exchange and files with the SEC under CIK 896264. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate USNA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for USANA HEALTH SCIENCES INC directly from SEC EDGAR.